P3 Health Partners Q2 EPS $(0.15) Misses $(0.05) Estimate, Sales $379.16M Miss $383.47M Estimate
Portfolio Pulse from Benzinga Newsdesk
P3 Health Partners (NASDAQ:PIII) reported Q2 EPS of $(0.15), missing the $(0.05) estimate by 200%. Sales were $379.16M, missing the $383.47M estimate by 1.12%. EPS decreased by 66.67% YoY, while sales increased by 15.22% YoY.
August 07, 2024 | 9:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
P3 Health Partners reported Q2 EPS of $(0.15), missing the $(0.05) estimate by 200%. Sales were $379.16M, missing the $383.47M estimate by 1.12%. EPS decreased by 66.67% YoY, while sales increased by 15.22% YoY.
The significant miss on EPS and slight miss on sales estimates are likely to negatively impact PIII's stock price in the short term. The YoY decrease in EPS and increase in sales provide mixed signals, but the overall negative earnings surprise is expected to weigh more heavily.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100